BCG & BBV-T1ST Enter into a Strategic Partnership to Stimulate Collaboration between Corporates and Deep Tech Startups - Learn More
Category
Biotech
GenEdit is a genome editing company with novel therapeutics. Their approach enables precise DNA sequence editing to cure severe diseases at a molecular level by delivering the breakthrough CRISPR/Cas9 protein.